Hassan Sadozai
Department of Biomedical Sciences, University of Guelph, Guelph, Ontario, N1G2W1, Canada
ABSTRACT
Green tea has been purported to have a protective effect against cardiovascular disease, hypertension, inflammatory disease and cancer. Recently, there has been considerable scientific interest in functional foods, or conventional foods that are demonstrated to have physiological benefits and/or reduce the risk of chronic disease beyond basic nutritional functions. This article examines green tea as a possible functional food for breast cancer. It is believed that the bioactive compound in green tea with purported anticancer potential is the catechin, (-)-epigallocatechin-3-gallate (EGCG). EGCG has been demonstrated to have antioxidant, anti-angiogenic and apoptotic effects using in vitro models. The results from epidemiological studies conducted in human populations are not statistically significant to warrant inclusion of green tea as a functional food against breast cancer. Nevertheless, certain trends observed in these studies and results from preclinical models necessitates further research into employing green tea as a functional food for breast cancer.
PDF References
How to cite this article
Hassan Sadozai, 2012. Green Tea as a Functional Food Against Breast Cancer: A Review. Pakistan Journal of Nutrition, 11: 754-759.
DOI: 10.3923/pjn.2012.754.759
URL: https://scialert.net/abstract/?doi=pjn.2012.754.759
DOI: 10.3923/pjn.2012.754.759
URL: https://scialert.net/abstract/?doi=pjn.2012.754.759
REFERENCES
- Bushman, J.L., 1998. Green tea and cancer in humans: A review of the literature. Nutr. Cancer, 31: 151-159.
CrossRefPubMedDirect Link - Bartholome, A., A. Kampkotter, S. Tanner, H. Sies and L.O. Klotz, 2010. Epigallocatechin gallate-induced modulation of FoxO signaling in mammalian cells and C. elegans: FoxO stimulation is masked via PI3K/Akt activation by hydrogen peroxide formed in cell culture. Arch. Biochem. Biophys., 501: 58-64.
CrossRef - Bray, F., P. McCarron and D.M. Parkin, 2004. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res., 6: 229-239.
CrossRefPubMedDirect Link - Cabrera, C., R. Artacho and R. Gimenez, 2006. Beneficial effects of green tea-A review. J. Am. Coll. Nutr., 25: 79-99.
PubMedDirect Link - Chung, F.L., J. Schwartz, C.R. Herzog and Y.M. Yang, 2003. Tea and cancer prevention: Studies in animals and humans. J. Nutr., 133: 3268S-3274S.
PubMedDirect Link - Gandini, S., H. Merzenich, C. Robertson and P. Boyle, 2000. Meta-analysis of studies on breast cancer risk and diet: The role of fruit and vegetable consumption and the intake of associated micronutrients. Eur. J. Cancer, 36: 636-646.
CrossRefPubMedDirect Link - Hastak, K., S. Gupta, N. Ahmad, M.K. Agarwal, M.L. Agarwal and H. Mukhtar, 2003. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene, 22: 4851-4859.
PubMed - Helmrich, S.P., S. Shapiro, L. Rosenberg, D.W. Kaufman and D. Slone et al., 1983. Risk factors for breast cancer. Am. J. Epidemiol., 117: 35-45.
Direct Link - Hsu, Y.C. and Y.M. Liou, 2011. The anti-cancer effects of (-)-Epigalocathine-3-gallate on the signaling pathways associated with membrane receptors in MCF-7 cells. J. Cell. Physiol., 226: 2721-2730.
CrossRef - Imai, K., K. Suga and K. Nakachi, 1997. Cancer-preventive effects of drinking green tea among a Japanese population. Prev. Med., 26: 769-775.
CrossRef - Kamangar, F., G.M. Dores and W.F. Anderson, 2006. Patterns of cancer incidence, mortality and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J. Clin. Oncol., 24: 2137-2150.
CrossRefPubMedDirect Link - Lambert, J.D. and R.J. Elias, 2010. The antioxidant and pro-oxidant activities of green tea polyphenols: A role in cancer prevention. Arch. Biochem. Biophys., 501: 65-72.
CrossRef - McKay, D.L. and J.B. Blumberg, 2002. The role of tea in human health: An update. J. Am. Coll. Nutr., 21: 1-13.
PubMed - Seely, D., E.J. Mills, P. Wu, S. Verma and G.H. Guyatt, 2005. The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: A systematic review and meta-analysis. Integr. Cancer Ther., 4: 144-155.
CrossRef - Singh, B.N., S. Shankar and R.K. Srivastava, 2011. Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications. Biochem. Pharmacol., 82: 1807-1821.
CrossRef - Smith-Warner, S.A., D. Spiegelman, H.O. Adami, W.L. Beeson and P.A. van den Brandt et al., 2001. Types of dietary fat and breast cancer: A pooled analysis of cohort studies. Int. J. Cancer, 92: 767-774.
CrossRef - Veronesi, U., P. Boyle, A. Goldhirsch, R. Orecchia and G. Viale, 2005. Breast cancer. Lancet, 365: 1727-1741.
CrossRef - Wu, A.H., M.C. Yu, C.C. Tseng, J. Hankin and M.C. Pike, 2003. Green tea and risk of breast cancer in Asian Americans. Int. J. Cancer, 106: 574-579.
CrossRefPubMedDirect Link - Wu, C.D. and G.X. Wei, 2002. Tea as a functional food for oral health. Nutrition, 18: 443-444.
Direct Link - Yang, C.S., L. Chen, M.J. Lee, D. Balentine, M.C. Kuo and S.P. Schantz, 1998. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol. Biomarkers Prev., 7: 351-354.
Direct Link - Yang, C.S., P. Maliakal and X. Meng, 2002. Inhibition of carcinogenesis by tea. Ann. Rev. Pharmacol. Toxicol., 42: 25-54.
CrossRefDirect Link